Vaxxa AB (FRA:7WA0) Total Liabilities: €1.17 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7WA0 Vaxxa AB FRA:7WA0
25 GF Score
Price €0.04
GF Value €0.05
View Full Analysis

What is Vaxxa AB Total Liabilities?

Vaxxa AB FRA:7WA0 +4.62% 25 Total Liabilities is €1.17 Mil as of Jun. 2026. GuruFocus rates FRA:7WA0 with a GF Score™ of 25/100 and a GF Value™ of €0.05.

Vaxxa AB's Total Liabilities for the quarter that ended in Jun. 2026 was €1.17 Mil.

Vaxxa AB's quarterly Total Liabilities increased from Dec. 2025 (€0.66 Mil) to Mar. 2026 (€1.18 Mil) but then declined from Mar. 2026 (€1.18 Mil) to Jun. 2026 (€1.17 Mil).

Vaxxa AB's annual Total Liabilities increased from Dec. 2023 (€0.69 Mil) to Dec. 2024 (€0.70 Mil) but then declined from Dec. 2024 (€0.70 Mil) to Dec. 2025 (€0.66 Mil).


Vaxxa AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Vaxxa AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxxa AB Total Liabilities Chart

Vaxxa AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.33 0.69 0.70 0.66

Vaxxa AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.20 0.66 1.18 1.17
FRA:7WA0
25GF Score
Vaxxa AB FRA:7WA0
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxxa AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Vaxxa AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=2.034-1.379
=0.66

Vaxxa AB's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=2.384-1.214
=1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €1.17 Mil mean?
Vaxxa AB (FRA:7WA0) has a Total Liabilities of €1.17 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Vaxxa AB and its competitors.
Is Vaxxa AB's Total Liabilities too high?
Vaxxa AB's current Total Liabilities is €1.17 Mil. Overall, Vaxxa AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Vaxxa AB's Total Liabilities compare to QH and SHOP?
Vaxxa AB's Total Liabilities of €1.17 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Software company?
A good Total Liabilities depends on the Software industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Vaxxa AB and its competitors. Vaxxa AB's current Total Liabilities is €1.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxxa AB stock overvalued right now?
Vaxxa AB (FRA:7WA0) has a current Total Liabilities of €1.17 Mil. The stock's GF Value™ is €0.05, compared to a current price of €0.04 — trading 27.6% below its estimated fair value. The current Total Liabilities is €1.17 Mil. Vaxxa AB's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Vaxxa AB (FRA:7WA0), the current Total Liabilities is €1.17 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaxxa AB (FRA:7WA0) Overvalued in 2026?

Based on GuruFocus' analysis, Vaxxa AB stock appears to be undervalued. The current stock price of €0.04 is trading 27.6% below its estimated GF Value™ of €0.05.

Key valuation signals for FRA:7WA0:

  • Total Liabilities: €1.17 Mil
  • GF Value™: €0.05 vs. price of €0.04 (27.6% below fair value)
  • GF Score™: 25/100

No single metric tells the full story. See the FRA:7WA0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vaxxa AB Business Description

Other Exchanges VAXXA:Sweden
Address Maskinvagen 27, Norrbotten, Lulea, SWE, 972 54
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.
25GF Score

Get the complete analysis for FRA:7WA0

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.04
Price
€0.05
GF Value